Perceptive Advisors »

Landos Biopharma shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Landos Biopharma (LABP) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Landos Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Landos Biopharma held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Landos Biopharma by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.4M 1.5M 3.66
2023-09-30 $5.8M 1.5M 3.88
2023-06-30 $6.3M 1.5M 4.21

More positions owned by Perceptive Advisors

Cerevel Therapeutics Hldng I (CERE)
Amicus Therapeutics (FOLD)
Lianbio Sponsored Ads (LIANY)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Inhibrx (INBX)
Soleno Therapeutics (SLNO)
Rhythm Pharmaceuticals (RYTM)
Immunovant (IMVT)
Iovance Biotherapeutics (IOVA)
Cymabay Therapeutics
Axsome Therapeutics (AXSM)
Medtronic SHS (MDT)
Cargo Therapeutics (CRGX)
Meiragtx Holdings (MGTX)

View all positions for Perceptive Advisors

Top funds holding Landos Biopharma

Perceptive Advisors
Deltec Asset Management
Jpmorgan Chase & Co
UBS Group
Wells Fargo & Company

View all funds holding Landos Biopharma